Literature DB >> 2535487

Muramyl dipeptide bound to poly-L-lysine substituted with mannose and gluconoyl residues as macrophage activators.

D Derrien1, P Midoux, C Petit, E Nègre, R Mayer, M Monsigny, A C Roche.   

Abstract

Poly-L-lysine modified with mannose derivatives, the residual cationic charges of which being neutralized by N-acylation, were synthesized and used as carriers of a macrophage activator (N-acetylmuramyl dipeptide, MDP). The influence of the acylating agent on the targeting efficiency was investigated: a hydrosolubilizing group such as a gluconoyl moiety led to very efficient carrier conjugates, while an acetyl group did not. The effect of sugar and acyl content of the polymers was assessed using these compounds as inhibitors of red blood cell agglutination by Concanavalin A. The binding and specific endocytosis of poly-L-lysine substituted with several mannose derivatives and gluconoyl residues (GlcAx-, Man(y)-PLK) have been determined by a quantitative flow cytometry analysis. MDP bound to these conjugates was much more efficient in vitro than free MDP in macrophage cytostasis assays.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535487     DOI: 10.1007/bf01050652

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  37 in total

1.  Alveolar macrophages. I. A simple technique for the preparation of high numbers of viable alveolar macrophages from small laboratory animals.

Authors:  P G Holt
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

Review 2.  Immunological problems of polymer-bound drugs.

Authors:  B Rihova; I Riha
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1985       Impact factor: 4.889

3.  Quantitation of the binding, uptake, and degradation of fluoresceinylated neoglycoproteins by flow cytometry.

Authors:  P Midoux; A C Roche; M Monsigny
Journal:  Cytometry       Date:  1987-05

Review 4.  Targeting of antiviral drugs bound to protein carriers.

Authors:  L Fiume; C Busi; A Mattioli; G Spinosa
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1988       Impact factor: 4.889

5.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

6.  A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.

Authors:  A Trouet; M Masquelier; R Baurain; D Deprez-De Campeneere
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Sugar-specific endocytosis of glycoproteins by Lewis lung carcinoma cells.

Authors:  A C Roche; M Barzilay; P Midoux; S Junqua; N Sharon; M Monsigny
Journal:  J Cell Biochem       Date:  1983       Impact factor: 4.429

8.  Fluorescein conjugates as indicators of subcellular pH. A critical evaluation.

Authors:  M J Geisow
Journal:  Exp Cell Res       Date:  1984-01       Impact factor: 3.905

9.  Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting.

Authors:  M Monsigny; A C Roche; P Midoux
Journal:  Biol Cell       Date:  1984       Impact factor: 4.458

10.  Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.

Authors:  M Parant; F Parant; L Chedid; A Yapo; J F Petit; E Lederer
Journal:  Int J Immunopharmacol       Date:  1979
View more
  10 in total

1.  Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides.

Authors:  C Pichon; M B Roufaï; M Monsigny; P Midoux
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Antileishmanial drug targeting through glycosylated polymers specifically internalized by macrophage membrane lectins.

Authors:  E Nègre; M L Chance; S Y Hanboula; M Monsigny; A C Roche; R M Mayer; M Hommel
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

Review 3.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

Review 4.  Gene therapy of cystic fibrosis: the glycofection approach.

Authors:  I Fajac; P Briand; M Monsigny
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

5.  Mannan-mediated gene delivery for cancer immunotherapy.

Authors:  Choon K Tang; Jodie Lodding; Gabriela Minigo; Dodie S Pouniotis; Magdalena Plebanski; Anja Scholzen; Ian F C McKenzie; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2007-03       Impact factor: 7.397

6.  Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling.

Authors:  Guoqiang Xu; Jeremy S Paige; Samie R Jaffrey
Journal:  Nat Biotechnol       Date:  2010-07-18       Impact factor: 54.908

7.  The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells.

Authors:  Ayelet David; Pavla Kopecková; Jindrich Kopecek; Abraham Rubinstein
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

8.  Sensitive, hydrosoluble, macromolecular fluorogenic substrates for human immunodeficiency virus 1 proteinase.

Authors:  F Anjuère; M Monsigny; Y Lelièvre; R Mayer
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

9.  Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates.

Authors:  E Bonfils; C Depierreux; P Midoux; N T Thuong; M Monsigny; A C Roche
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

10.  Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells.

Authors:  P Midoux; C Mendes; A Legrand; J Raimond; R Mayer; M Monsigny; A C Roche
Journal:  Nucleic Acids Res       Date:  1993-02-25       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.